| pubmed-article:20518617 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20518617 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:20518617 | lifeskim:mentions | umls-concept:C0020538 | lld:lifeskim |
| pubmed-article:20518617 | lifeskim:mentions | umls-concept:C0001554 | lld:lifeskim |
| pubmed-article:20518617 | lifeskim:mentions | umls-concept:C0011860 | lld:lifeskim |
| pubmed-article:20518617 | lifeskim:mentions | umls-concept:C0021186 | lld:lifeskim |
| pubmed-article:20518617 | lifeskim:mentions | umls-concept:C0136123 | lld:lifeskim |
| pubmed-article:20518617 | lifeskim:mentions | umls-concept:C1273870 | lld:lifeskim |
| pubmed-article:20518617 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
| pubmed-article:20518617 | lifeskim:mentions | umls-concept:C0725066 | lld:lifeskim |
| pubmed-article:20518617 | lifeskim:mentions | umls-concept:C0205202 | lld:lifeskim |
| pubmed-article:20518617 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:20518617 | pubmed:dateCreated | 2010-6-14 | lld:pubmed |
| pubmed-article:20518617 | pubmed:abstractText | The increase in type 2 diabetes mellitus is associated to cardiovascular morbidity and mortality. This review focuses on the benefits of the fixed-dose combination of perindopril and indapamide on cardiovascular and renal end points in the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation) trial. | lld:pubmed |
| pubmed-article:20518617 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20518617 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20518617 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20518617 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20518617 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20518617 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20518617 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20518617 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20518617 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20518617 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:20518617 | pubmed:issn | 1744-7666 | lld:pubmed |
| pubmed-article:20518617 | pubmed:author | pubmed-author:GhiadoniLoren... | lld:pubmed |
| pubmed-article:20518617 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20518617 | pubmed:volume | 11 | lld:pubmed |
| pubmed-article:20518617 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20518617 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20518617 | pubmed:pagination | 1647-57 | lld:pubmed |
| pubmed-article:20518617 | pubmed:dateRevised | 2011-8-25 | lld:pubmed |
| pubmed-article:20518617 | pubmed:meshHeading | pubmed-meshheading:20518617... | lld:pubmed |
| pubmed-article:20518617 | pubmed:meshHeading | pubmed-meshheading:20518617... | lld:pubmed |
| pubmed-article:20518617 | pubmed:meshHeading | pubmed-meshheading:20518617... | lld:pubmed |
| pubmed-article:20518617 | pubmed:meshHeading | pubmed-meshheading:20518617... | lld:pubmed |
| pubmed-article:20518617 | pubmed:meshHeading | pubmed-meshheading:20518617... | lld:pubmed |
| pubmed-article:20518617 | pubmed:meshHeading | pubmed-meshheading:20518617... | lld:pubmed |
| pubmed-article:20518617 | pubmed:meshHeading | pubmed-meshheading:20518617... | lld:pubmed |
| pubmed-article:20518617 | pubmed:meshHeading | pubmed-meshheading:20518617... | lld:pubmed |
| pubmed-article:20518617 | pubmed:meshHeading | pubmed-meshheading:20518617... | lld:pubmed |
| pubmed-article:20518617 | pubmed:meshHeading | pubmed-meshheading:20518617... | lld:pubmed |
| pubmed-article:20518617 | pubmed:meshHeading | pubmed-meshheading:20518617... | lld:pubmed |
| pubmed-article:20518617 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20518617 | pubmed:articleTitle | Management of high blood pressure in type 2 diabetes: perindopril/indapamide fixed-dose combination and the ADVANCE trial [corrected]. | lld:pubmed |
| pubmed-article:20518617 | pubmed:affiliation | Department of Internal Medicine, University of Pisa, Via Roma 67, 56126 Pisa, Italy. l.ghiadoni@med.unipi.it | lld:pubmed |
| pubmed-article:20518617 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20518617 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
